Research on the Removal of Levamisole Residues in Bovine, Ovine, Caprine, Porcine and Poultry Tissues
Abstract
:1. Introduction
2. Materials and Methods
2.1. Reagents Used
- –
- Levamisole hydrochloride, reference standard, Fluka, Germany.
- –
- Acetonitrile HPLC, gradient-grade, Merck.
- –
- Methanol HPLC, Merck.
- –
- Ethyl acetate HPLC, Biosolve.
- –
- Potassium hydroxide p.a.
- –
- Hydrochloric acid conc., d = 1.19 g/L.
- –
- Formic acid 98–100%, Riedel-de Haen.
- –
- Hydrochloric acid 0.5 M: 41.2 mL HCl conc. dilute to 1 l with water.
- –
- Potassium hydroxide 50%.
- –
- Chloroform p.a.
- –
- Anhydrous sodium sulfate p.a.
- –
- Levamisole stock standard solution (0.1 mg/mL): Weigh accurately 11.8 mg of levamisole hydrochloride, reference standard, Fluka, dissolve in dimethylsulfoxide and make up to 100 mL with methanol. The solution is stable for up to 2 months in the refrigerator.
- –
- Standard solutions (1 µg/mL): Prepare by diluting 1 mL of stock solution to 100 mL with methanol.
- –
- Working standard solutions (0.01–0.10 µg/mL): Prepare at least 5 working standard solutions in the respective range by diluting the standard solution of 1 µg/mL to 1 mL with purified sample extract witness (matrix), such as in Table 1:
2.2. Apparatus and Materials Used
- –
- Analytical balance KERN Abj.
- –
- Waters 2695 (Waters Corporation, Milford, MA, USA) high performance liquid chromatograph, equipped with automatic injection system, XBridge RP 18 analytical column (150 mm × 2.1 mm, 3.5 µm), thermostat with controlled temperature at 40 °C, pump system with ternary gradient, solvent degasser.
- –
- Quatro micro MS–MS detector (Micromass) equipped with ESI interface. The mass spectrometer is controlled by MassLynx software, version 4.1 (Waters Corporation, 34 Maple Street, Milford, MA, USA).
- –
- Heidolph Reax Control vortex agitator.
- –
- Ultraturax IKA T25.
- –
- Centra MP 4R refrigerated centrifuge, with 40 mL and 15 mL polypropylene centrifuge tubes.
- –
- Sonorex RK 100H ultrasonic bath.
- –
- Ultrapure water production system SG GmbH.
- –
- Mixer, type “Moulinette” Moulinex.
- –
- Turbo-Vap Evaporator (Zymark, Germany).
2.3. Sample Preparation
- –
- Freshly taken specimens are kept cold before and during shipment to the laboratory. Once they arrive at the laboratory, if they cannot be analyzed on the day of reception, they are kept in the freezer (−10 °C) until the time of analysis.
- –
- If the samples are frozen, let them thaw, but keep them as cold as possible. The fat and related tissues are removed from the kidney or liver. Finely chop or chop the tissue in a mixer with knives. Store in the freezer (−10 °C) before analysis.
2.4. Extraction and Purification
- –
- About 10 g of minced and homogenized tissue, at mixer, type “Moulinette” Moulinex.DD55210, 600 W, at room temperature, weighed to the nearest 0.01 g, were transferred into a 50 mL polypropylene centrifuge tube with a lid.
- –
- For recovery, it was fortified to the desired concentration. The spiking was performed after homogenization. The spiking was performed on the 10 g of homogeneous sample transferred to the centrifuge tube. The fortification was carried out with levamisole standard solution (0.1 mg/mL) prepared as follows: 11.8 mg of levamisole hydrochloride, reference standard, Fluka, Germany. Dissolve in dime-thylsulfoxide and make up to 100 mL with methanol. It was allowed to sit for approximately 15 min to ensure that the fortification solution was absorbed.
- –
- Five grams of anhydrous sodium sulfate was added to the sample and 1 mL of 50% KOH.
- –
- Fifteen milliliters of ethyl acetate was added and homogenized in the mixer at maximum speed. The homogenized mixture is stirred with a horizontal shaker for 10 min and then left to stand for another 10 min.
- –
- Centrifuged at 4000 rpm for 15 min at room temperature.
- –
- The upper organic layer was transferred to another centrifuge tube.
- –
- The sample was re-extracted under the same conditions (10 minutes stirring in the ultrasonic bath. Sonorex RK 100H), with another 15 mL of ethyl acetate and centrifuged for 5 min.
- –
- Five milliliters of 0.5 M HCl was added to the combined ethyl acetate extracts.
- –
- After centrifugation, the organic layer was discarded and the acid layer was transferred to a polypropylene tube.
- –
- The solution was brought to alkaline pH (10.5) by the addition of 1 mL of 50% KOH.
- –
- Two milliliters of chloroform was added and centrifuged at 2500 rpm for 5 min.
- –
- The chloroform layer was transferred to a test tube and evaporated to dryness under a stream of nitrogen.
- –
- The residue was dissolved in 0.6 mL mobile phase consisting of 0.1% formic acid in water-acetonitrile (50:50, v/v) by stirring. Heated to 50 °C in a water bath for 5 min. After verting in a vortex, it was made up to 1 mL with mobile phase. After cooling to room temperature, the purified sample extract was filtered through a 0.2 μm filter PTFE into an autosampler vial.
2.5. LC-MS–MS Analysis
2.5.1. Working Parameters LC
- –
- Analytical column: Xbridge RP 18 (150 mm × 2.1 mm, 3.5 μm); flow rate: 0.25 mL/min; mobile phase: A—Water with formic acid 0.2% v/v, B—Acetonitrile, A/B = 25:75; injection volume: 20 μL; temperature of the column thermostat: 35 °C.
- –
- At the exit of the analytical column, the compounds are ionized by the ESI + method and analyzed in multiple-reaction monitoring (MRM) mode with MS Micromass Quatro micro Electrospray Ionization/Atmospheric Pressure Ionization (ESI/API).
2.5.2. Working Parameters MS
- –
- MS applied in positive ESI mode; desolvation gas flow (nitrogen): 350 L/h; MS applied in positive ESI mode. Desolvation gas flow (nitrogen): 350 L/h; dissolving temperature: 350 °C; ionization source temperature: 120 °C; tuning of the device was performed by direct infusion (flow 10 μL/min) of standard solutions (concentration 1 μg/mL levamisole) using a 250 μL syringe pump (Hamilton).
- –
- For fragmentation, the collision gas flow (argon) (2.5 × 10−3 torr) and the collision energy were adjusted to obtain an optimal fragmentation of the molecular ion.
- –
- The retention time and optimal parameters for levamisole are given below (Table 2):
- –
- Capillary voltage: 3.5 kV; voltage at the extractor: 1 V; the MS control was performed with the MassLynx data system, version 4.1; the fragmentation ion with the highest intensity was chosen for quantification, 205.0 > 177.8.
- –
- The evaluation of the areas, the regression analysis of the standard curve and the calculation of the concentrations were performed with the QuanLynx V4.1 program.
3. Results
3.1. Calculation of Recovery from Samples, Residue Content and Quality Control
3.1.1. Calculation of the Recovery Percentage from Samples
- –
- The calibration curve was drawn based on the results obtained with the calibration standard solutions. The linearity of the response was checked. The mathematical relationship between the detector response and the analyte concentration in the matrix was established. For this, a series of standard solutions of levamisole prepared in matrices with concentrations between 0.01 and 1.0 µg/mL were analyzed, which under the conditions described in the working method (10 g sample/1 mL final purified extract) corresponds to 1 to 100 µg/kg. (Appendix B, Figure A9).
- –
- The percentage of recovery from the samples was calculated by comparing the result obtained for the sample with that obtained for the standard solution of corresponding concentration.
- %R—percentage of recovery from the sample;
- x1—the measured value for the control;
- x2—the measured value for the treated sample;
- xad—the amount added.
3.1.2. Calculation of Residue Content
- cpr—concentration of levamisole in the final sample extract, read from the calibration curve, in μg/mL
- R—recovery percentage.
3.1.3. Quality Control
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Appendix A. Chromatograms
Appendix B
References
- Available online: https://pubchem.ncbi.nlm.nih.gov/compound/27944 (accessed on 9 September 2022).
- Dolezalova, M.; Tkaczykova, M. LC determination of the enantiomeric purity of levamisole using stationary phase with bonded naphthylethylcarbamoylated-b-cyclodextrin. J. Pharm. Biomed. Anal. 2001, 25, 407–415. [Google Scholar] [CrossRef]
- Tyrpenou, A.E.; Xylouri-Frangiadaki, E.M. Determination of Levamisole in Sheep Muscle Tissue by High-Performance Liquid Chromatography and Photo Diode Array Detection. Chromatographia 2006, 63, 321–326. [Google Scholar] [CrossRef]
- Potârniche, A.V.; Mickiewicz, M.; Olah, D.; Cerbu, C.; Spînu, M.; Hari, A.; Györke, A.; Moroz, A.; Czopowicz, M.; Várady, M.; et al. First Report of Anthelmintic Resistance in Gastrointestinal Nematodes in Goats in Romania. Animals 2021, 11, 2761. [Google Scholar] [CrossRef] [PubMed]
- El Kholy, H.; Kemppainen, B. Liquid chromatographic method with ultraviolet absorbance detection for measurement of levamisole in chicken tissues, eggs and plasma. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2003, 796, 371–377. [Google Scholar] [CrossRef]
- Zanon, R.B.; Cerozi, B.S.; Silva, T.S.C.; Cyrino, J.E.P. Pharmacokinetic of levamisole in speckled surubim Pseudoplatystoma corruscans. J. Vet. Pharmacol. Ther. 2012, 36, 298–301. [Google Scholar] [CrossRef]
- Ince, S.; Kozan, E.; Kucukkurt, I.; Bacak, E. The effect of levamisole and levamisole + vitamin C on oxidative damage in rats naturally infected with Syphacia muris. Exp. Parasitol. 2010, 124, 448–452. [Google Scholar] [CrossRef]
- Gross, R.L.; Brucker, J.; Bahce-Altuntas, A.; Abadi, M.A.; Lipoff, J.; Kotlyar, D.; Barland, P.; Putterman, C. A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine. Clin. Rheumatol. 2011, 30, 1385–1392. [Google Scholar] [CrossRef]
- Scheinfeld, N.; Rosenberg, J.D.; Weinberg, J.M. Levamisole in dermatology: A review. Am. J. Clin. Dermatol. 2004, 5, 97–104. [Google Scholar] [CrossRef]
- Won, T.H.; Park, S.Y.; Kim, B.S.; Seo, P.S.; Park, S.D. Levamisole Monotherapy for Oral Lichen Planus. Ann. Dermatol. 2009, 21, 250–254. [Google Scholar] [CrossRef]
- Kuropka, P.; Małolepsza-Jarmołowska, K.; Dobrzyński, M.; Tarnowska, M.; Majda, J.; Janeczek, M.; Żybura-Wszoła, L.; Gamian, A. Effect of a Single and Triple Dose of Levamisole on Hematological Parameters in Controlled Inflammation Model. Animals 2022, 12, 2110. [Google Scholar] [CrossRef]
- Shea, J.L. Bioanalytical methods for quantitation of levamisole, a widespread cocaine adulterant. Clin. Chem. Lab. Med. 2013, 51, 205–212. [Google Scholar] [CrossRef] [PubMed]
- Dreassi, E.; Corbini, G.; La Rosa, C.; Politi, N.; Corti, P. Determination of levamisole in animal tissues using liquid chromatography with ultraviolet detection. J. Agric. Food Chem. 2001, 49, 5702–5705. [Google Scholar] [CrossRef] [PubMed]
- Adediran, O.; Uwalaka, E. Effectiveness Evaluation of Levamisole, Albendazole, Ivermectin, and Vernonia amygdalina in West African Dwarf Goats. J. Parasitol. Res. 2015, 2015, 706824. [Google Scholar] [CrossRef] [PubMed]
- Soudkolaei, A.S.; Kalidari, G.A.; Borji, H. Anthelmintic eficacy of fenbendazole and levamisole in native fowl in northern Iran. Parasites Vectors 2021, 14, 104. [Google Scholar] [CrossRef] [PubMed]
- Wallgren, P.; Pettersson, E. Lungworms (Metastrongylus spp.) demonstrated in domestic pigs with respiratory disease: Was there a clinical relevance? Porc. Health Manag. 2022, 8, 16. [Google Scholar] [CrossRef]
- EL-Kholy, H.; Kemppainen, B.; Ravis, W.; Hoerr, F. Pharmacokinetics of levamisole in broiler breeder chickens. J. Vet. Pharmacol. Ther. 2006, 29, 49–53. [Google Scholar] [CrossRef]
- Gokbulut, C.; Yalinkilinc, H.S.; Aksit, D.; Veneziano, V. Comparative pharmacokinetics of levamisole-oxyclozanide combination in sheep and goats following per os administration. Can. J. Vet. Res. 2014, 4, 316–320. [Google Scholar]
- De Ruyck, H.; Daeseleire, E.; De Ridder, H.; Van Renterghem, R. Development ans validation of a liquid chromatographic-electrospray tandem mass spectrometric multiresidue method for anthelmintics in milk. J. Chromatogr. A 2002, 976, 181–194. [Google Scholar] [CrossRef]
- Hess, C.; Ritke, N.; Broecker, S.; Madea, B.; Musshoff, F. Metabolism of levamisole and kinetics of levamisole and aminorex in urine by means of LC-QTOF-HRMS and LC-QqQ-MS. Anal. Bioanal. Chem. 2013, 405, 4077–4088. [Google Scholar] [CrossRef]
- Chang, E.; Yamashita, K.; Arora, R. Multi-Residue Screening of Veterinary Drugs (I) and (II) in Meat According to the Japan Positive List Using Cartridge-Based SPE and LC/MS/MS; Application note SI-02112; Varian, Inc.: Crawley, UK, 2010. [Google Scholar]
- Directive 2002/657/EC; Commission Decision of 12 August 2002 Implementing Directive 96/23/EC on the Performance of Analytical Methods and the Interpretation of Results. Publication Office of the European Union: Luxembourg, 2002.
- European Union. Council Directive 96/23/EC of 29 April 1996 on Measures to Monitor Certain Substances and Residues Thereof in Live Animals and Animal Products and Repealing Directives 85/358/EEC and 86/469/EEC and Decisions 89/187/EEC and 91/664/EEC; European Union: Brussels, Belgium, 1996. [Google Scholar]
- Bogdan, J.A.; Marriner, S.E.; Galbraith, E.A. Pharmacokinetics of levamisole in sheep. Res. Vet. Sci. 1982, 32, 124–126. [Google Scholar] [CrossRef]
- Woestenborghs, R.; Michielsen, L.; Heykants, J. Determination of levamisole in plasma and animal tissues by gas chromatography with thermionic specific detection. J. Chromatogr. B Biomed. Sci. Appl. 1981, 224, 25–32. [Google Scholar] [CrossRef]
- Xu, J.; Xiao, S.; Dong, W.; Sui, K.; Cao, J.; Diao, W.; Zhang, J. Determination of levamisole residue in animal livers by two liquid-liquid extraction steps-gas chromatography-mass spectrometry. Chin. J. Chromatogr. 2012, 30, 922–925. [Google Scholar] [CrossRef] [PubMed]
- El-Kholy, H.; Kemppainen, B.W. Levamisole residues in chicken tissues and eggs. Poult. Sci. 2005, 84, 9–13. [Google Scholar] [CrossRef] [PubMed]
- Heitzman, R.J. Veterinary Drug Residues—Residues in Food Producing Animals and Their Products: Reference Materials and Methods, 2nd ed.; EUR 15127 EN; Commission of the European Communities: Brussels, Belgium, 1994. [Google Scholar]
- Ellison, S.L.R.; Roesslein, M.; Williams, A. Quantifying Uncertainty in Analytical Measurement; Eurachem/Citac Guide; Eurachem/CITAC: Teddington, UK, 2000. [Google Scholar]
- Gao, P.; Zhang, P.; Guo, Y.; He, Z.; Dong, Y.; Tang, Y.; Guan, F.; Zhang, T.; Xie, K. Determination of Levamisole and Mebendazole and Its Two Metabolite Residues in Three Poultry Species by HPLC-MS/MS. Foods 2021, 10, 2841. [Google Scholar] [CrossRef]
- ISO 5725-2:1994; Accuracy (Trueness and Precision) of Measurement Methods and Results, Part 1: General Principles and Definitions. ISO: Geneva, Switzerland, 1994.
- ISO 5725-2:1994; Accuracy (Trueness and Precision) of Measurement Methods and Results—Part 2: Basic Method for the Determination of Repeatability and Reproducibility of a Standard Measurement Method. ISO: Geneva, Switzerland, 1994.
No. Standard Solution | 1 | 2 | 3 | 4 | 5 |
---|---|---|---|---|---|
Levamisole concentration, µg/mL | 0.01 | 0.025 | 0.050 | 0.075 | 0.10 |
Standard solution (1 µg/mL), µL | 10 | 25 | 50 | 75 | 100 |
Final volume, mL | 1 | 1 | 1 | 1 | 1 |
Component | Retention Time (min) | Precursor Ion (m/z) | Fragmentary Ions (m/z) | Cone Voltage (V) | Collision Energy (eV) |
---|---|---|---|---|---|
Levamisole | 2.85 | 205.2 | 90.5 | 35 | 38 |
122.6 177.8 * | 35 35 | 28 20 |
Analit | Precursor Ion [M+H]+ | Fragment Ions, m/z | The Relative Intensity of the Ions, % | Max. Tolerance Allowed, % |
---|---|---|---|---|
Levamisole | 205.2 | 177.8; 90.5 | 51.3 | 20 |
Tissue | Quantity Added (x) µg/kg | Quantity Found (y) µg/kg | y = ax +b | CCα µg/kg | CCβ µg/kg |
---|---|---|---|---|---|
Muscle | 10 | 8.89 | y = 1.006x − 1.17 | 10.3 | 11.7 |
Liver | 100 | 93.14 | y = 1.038x − 10.66 | 104.4 | 115.6 |
Kidney | 10 | 9.06 | y = 1.041x − 1.35 | 10.4 | 11.8 |
Fat | 10 | 8.32 | y = 0.859x − 0.27 | 10.2 | 12.1 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ciucă, V.C.; Rusănescu, C.O.; Safta, V.V. Research on the Removal of Levamisole Residues in Bovine, Ovine, Caprine, Porcine and Poultry Tissues. Separations 2022, 9, 261. https://doi.org/10.3390/separations9090261
Ciucă VC, Rusănescu CO, Safta VV. Research on the Removal of Levamisole Residues in Bovine, Ovine, Caprine, Porcine and Poultry Tissues. Separations. 2022; 9(9):261. https://doi.org/10.3390/separations9090261
Chicago/Turabian StyleCiucă, Viviana Carmen, Carmen Otilia Rusănescu, and Victor Viorel Safta. 2022. "Research on the Removal of Levamisole Residues in Bovine, Ovine, Caprine, Porcine and Poultry Tissues" Separations 9, no. 9: 261. https://doi.org/10.3390/separations9090261